ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0042737;drug catabolic process;4.0;0.5228814991548376;0.5114407495774188;6.80374977708177;51.78963646143837;4.793467005972133;0.0017333525247175516;0.49513812560442705;[, ACHE, DPYS, MPO, CTSH, CHIT1, POR, DPYD, PXDN, CHI3L2, CHI3L1, NR1I2, CYP3A4, CYP3A5, ACAT1, NT5E]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD28, PTPN6, CD24, CARD11]
GO:0033396;beta-alanine biosynthetic process via 3-ureidopropionate;9.0;1.0;0.896240625180289;9.628524252492122;478.072002543902;9.777073627680469;0.01600063968827545;0.896240625180289;[UPB1]
GO:0006212;uracil catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;1126.0761526232816;9.083926447120524;0.03768875542555955;0.8607930461318132;[DPYS, DPYD]
GO:0006520;cellular amino acid metabolic process;6.0;0.406884124246779;0.526562374713534;6.526182243879872;77.81072980309767;4.002522082136061;0.0026042551013992716;0.5278094780068945;[CPOX, MCCC2, KMO, UPB1, MTHFD1, PADI4, GMPS, SLC1A3, GLYAT, ACMSD, ACAT1, AGXT2, SLC6A6, HAL, ALDH6A1, P4HA2, NOX4, ALDH18A1, SERINC5, HIBADH, DPYS, PFAS, GHR, HNF4A, HIBCH, ARG1, CAD, PRODH2, SLC7A5, SLC7A7, SLC7A8, DPYD, BCAT1, GART, SLC3A1, SLC25A21]
GO:0009313;oligosaccharide catabolic process;5.0;0.6763753087927167;0.6284286662572787;8.458452999841867;68.60352119966694;7.069023426578259;0.0022960981153922187;0.6517511986393402;[GM2A, SLC3A1]
GO:0008202;steroid metabolic process;4.0;0.566269677792466;0.5331348388962329;7.508260716292031;35.315100643705854;4.247644540169047;0.001181964637017687;0.4672247393199168;[CYP1B1, CUBN, PDGFRA, UGT2B15, UGT2B17, CH25H, SLC27A2, CFTR, ABCA1, OSBPL7, VDR, SRD5A3, DHCR24, ADM, SULT4A1, YWHAH, NR1I2, HSD17B4, UGT2B28, LRP2, CYP3A4, CYP3A5, CYP3A7, SPP1]
GO:0006210;thymine catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;1047.620013338454;8.67846133901236;0.03506289904963761;0.8400575416471059;[ALDH6A1, DPYS, DPYD]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[PYCARD, PPP2R1A, AKT1, EPHB2, MEN1, PAQR3, PRKCD, TSC2, SFRP2, PRKAR1B, THY1, SOCS2, FLRT2, PRKAR2B, SFN, LYN, CAV1, PLK1, NR2F2, PTPRC, PKIG, CDKN1A, LRRC4, TNFAIP3, PTPN22, HHEX, DUSP10, LRRTM4, NUP62, DUSP2, MYOCD, DUSP1, BGN, IRAK3, GP1BA, SIRT1, DUSP6, DCN, CEACAM1, IL1B, LRRC19, CDKN2C, PODN, PTPN6, PKN1]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[HHLA2, IL18, PYCARD, IL23A, CD24, IL12RB1, IL6R, ICOSLG]
GO:0046426;negative regulation of JAK-STAT cascade;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;286.97803335492995;5.845247994956144;0.009604896512927369;0.6951668794741764;[LRRC19, CAV1, LRRC4, BGN, GP1BA, PODN, DCN, SOCS2, FLRT2, HGS, PPP2R1A, LRRTM4, BCL3]
GO:0009822;alkaloid catabolic process;5.0;0.6799073451904818;0.6301946844561612;8.656663669463155;138.8294026698821;8.67846133901236;0.004646495169010236;0.7340579283277371;[CYP3A4, CYP3A5]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[CDA, DPYS, TK1, ACPP, FBP1, HM13, SAMHD1, CD79A, VASP, IMPDH2, CD247]
GO:0019482;beta-alanine metabolic process;7.0;0.7980440201809971;0.7499413753476991;9.370695143190021;112.21837679303422;8.390779266560578;0.0037558480812805665;0.7800242071602487;[DPYS, DPYD, UPB1]
GO:0046135;pyrimidine nucleoside catabolic process;8.0;0.7307253602413294;0.7403626801206646;9.333724712271477;1255.5710096994353;6.686031174322154;0.04202283175409332;0.7169239451870815;[CDA, DPYS, UPB1, NT5E, DPYD, UPP1]
GO:0052695;cellular glucuronidation;9.0;0.8653626801206646;0.8289219652406215;9.446202695698167;85.04062765322598;6.8867018697843045;0.0028462332759574376;0.7484268790654467;[UGT2B15, UGT2A3, UGT2B17, UGT2B28]
GO:0002933;lipid hydroxylation;6.0;1.0;0.8231203125901445;9.628524252492122;42.73803676251887;7.9853141584524145;0.0014304036287055674;0.7314896500084853;[CYP4A22, CYP3A4, CYP3A5, CYP3A7]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, IFNGR1, GPR35, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL1, BIRC5, LCP1, CX3CR1, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, PML, IL2RB, PTPN6, IL1RN, IFI30, IFIT1, IFIT3, IFIT2, TNFSF11, RSAD2, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, IL18, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, CD74, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, NFKBIA, IL6, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, CAMK2D, SAMHD1, NCAM1, MX2, CD4, LTBR]
GO:1990822;basic amino acid transmembrane transport;10.0;0.7508913569872202;0.7906866903545304;9.277126365654233;267.5048622669104;7.697632086000634;0.008953147001327533;0.8088982747154926;[SLC7A7, SLC3A1]
GO:0001819;positive regulation of cytokine production;5.0;0.5089359064165209;0.5447089650691808;6.969264215559344;44.25546033084785;3.8109268885567773;0.001481190429944989;0.48513199016793795;[IL1RN, SERPINE1, MYB, DHX58, C3AR1, CYP1B1, RSAD2, SLC11A1, MIF, EREG, IL23A, PRKCQ, HHLA2, TWIST1, GATA3, LY9, KLRK1, HMOX1, CD14, ELANE, EGR1, FZD5, PRG2, AZU1, CD28, NOX1, ORM1, CD40, BRCA1, CD3E, IFIH1, FFAR2, CCR7, CD36, CD34, CCR2, HLA-DPA1, HAVCR2, IL10, ANXA1, FCER1G, SYK, NFAM1, IL18, IL17RB, MMP12, TLR1, IL1B, IGHD, RARA, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, PTAFR, PTGS2, CD58, CCL19, IL12RB1, IL12RB2, CD74, CCL20, CARD9, LILRB2, SULF1, SULF2, NLRP12, CD40LG, HLA-DPB1, IL18R1, PF4, IL17A, CD86, CD83, CD80, TNF, CLU, PYCARD, CLEC5A, IL6R, POSTN, F2R, ADCYAP1, CARD11, CD274, CSF1R, C5AR1, LY96, DDX60, NLRP3, TGFB1, NFKB1, IL6, NR4A3, BCL3, HPSE, MYD88, LRRK2, HMGB2, PTPN22, PDE4B, CHUK, DDX58, FGR, IFNG, LTA, IRF7, XCL1, CEBPB, NOD2, THBS1, HSPD1, LUM, MAPK14, MAPK13, CD2, CD4, CD6, CD244]
GO:0015811;L-cystine transport;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;254.95955250308688;8.390779266560578;0.008533266773578137;0.8443458537639685;[SLC3A1]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, GATA3, THY1, PAK1, INPP5D, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
